The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
IMJUDO tremelimumab 300 mg/ 15 mL concentrated injection vial (387300)
ARTG Name
IMJUDO tremelimumab 300 mg/ 15 mL concentrated injection vial
Product name
IMJUDO tremelimumab 300 mg/ 15 mL concentrated injection vial
ARTG Date
Registration Type
Medicine
Therapeutic good type
Medicine
Sponsor
Ingredients
tremelimumab
Licence category
RE
Licence status
A
Summary